+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07112924

Observational Evaluation of CCM Therapy Using Impulse Dynamics Devices in Heart Failure Patients

Led by Impulse Dynamics · Updated on 2026-10-27

5500

Participants Needed

30

Research Sites

50 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the long-term safety and effectiveness of CCM therapy in treating heart failure in a real-world setting. This global, observational study includes both prospective and retrospective patients who have received or will receive CCM therapy using Impulse Dynamics systems, including future technologies such as CCM-D. Participants will be followed for at least 5 years to gather comprehensive data. Participants receive CCM therapy through an Impulse Dynamics device as part of their regular care. The study does not assign treatments but observes patients who have been implanted or will be implanted with these devices. The registry collects data from multiple centers worldwide, tracking outcomes over time without altering the standard treatment process. During the study, participants will be monitored regularly to assess hospitalizations related to heart failure, device- or procedure-related complications, mortality, functional capacity, and quality of life among other measures. Assessments include questionnaires like the Kansas City Cardiomyopathy Questionnaire and evaluations of clinical outcomes, device compliance, and cardiovascular changes. Follow-up will last for at least five years, ensuring long-term safety and effectiveness data collection.

CONDITIONS

Brief Title

CCM OPEN HF Registry

Research Team

K

Karl Van Wygerden

E

Erika Mednick

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here